Prescribing information

Identifying Progression

Regular monitoring of your patients with gastroenteropancreatic neuroendocrine tumours (GEP-NETs) is essential to detect progression and to determine the need for a change in therapy.1  The progression brochure and slide deck are easy to read guides on how to understand and identify disease progression in patients with GEP-NETs.

Referring a patient for PRRT?

If you are referring your patient for PRRT, it is important you consider the following questions:

  • Do you have the patient’s full medical history?
  • What are the patient’s haematology results?
  • What are the patient’s tumour markers?
  • What is their current cardiac status?
  • What is the evidence for progression?
  • Do you have the patient’s background information? 


1. Merino-Casabiel X, et al. Clin Transl Oncol. 2018;20:1522–8.
AAA-Lu177-UK-2148 | October 2023

Ask Speakers


Medical Information Request